Key facts
- It has raised $622.6M across 5 recorded rounds; the latest was Later Stage VC ($434.5M) in Jun 2021.
- Pivot Bio has filed 6 Form Ds with the SEC since 2014, most recently Aug 2021 ($434.5M sold to 19 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Pivot Bio
Create free account
No card required
Funding rounds
5 roundsAbout Pivot Bio
PA Mark — not yet priced
Pivot Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Pivot Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Pivot Bio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.